Jump to content

University of Florida Obsessive–Compulsive Disorder Program

From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by BD2412 (talk | contribs) at 01:17, 3 November 2013 (Research: BLP using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
University of Florida Obsessive Compulsive Disorder Program
Company typeOutpatient Clinic
Headquarters,
United States
Area served
International
Key people
(Directors)
Gary R. Geffken, Ph.D., Joseph P.H. McNamara, Ph.D., Cindi G. Flores, Ph.D.
ServicesExposure and response prevention Cognitive Behavioral Therapy Medication Management
Websiteufhealth.org/medical-psychology-shands-uf

The University of Florida Obsessive Compulsive Disorder (UF OCD) Program is a treatment and research clinic in the Department of Psychiatry at the University of Florida. The clinic is located in Gainesville, Florida.

History of the Clinic

Created by Drs. Wayne Goodman and Gary Geffken, the UF OCD program focuses on training and treatment of refractory Obsessive–compulsive disorder. The program originated as a stand alone clinic within the Department of Psychiatry at the University of Florida and has expanded to a clinic integrated with Child and Adolescent Psychiatry and the University of Florida Eating Disorder Recovery Center. In addition, UF OCD program staff collaborate with the Florida Recovery Center [1] at the University of Florida.

The UF OCD Program uses cognitive behavioral therapy with exposure and response prevention (CBT-E/RP), a empirically validated treatment for OCD and other anxiety disorders. The clinic treats both children and adults with OCD and has a success rate higher than the national average.[1]

Research

In addition to clinical services, the clinic serves as a functioning research facility. The clinic has been used as a site for the validation of the Children’s Yale-Brown Obsessive Compulsive Scale [2] as well as a treatment site for several federally funded studies, such as a recent R01 federally funded from the National Institute of Mental Health[3] to study the pharmaceutical and behavioral treatment for pediatric OCD. This study has yielded several important studies in the past year, such as the clinical implications of co-morbid depression,[4] with several more currently in preparation.

Additionally, the program has been a part of numerous studies examining family factors that impact OCD treatment outcome,[5] the importance of the relationship between therapist and patient during OCD treatment,[6] and other novel psychopharmacological agents[7] that may improve outcome.

Training

The UF OCD Program is one of the few training programs in the United States recognized by the International OCD Foundation (IOCDF). The program trains graduate, intern, and resident level trainees in the implementation and treatment design of CBT-E/RP.

Faculty

The UF OCD Program is an collaborative program staffed by psychologists and psychiatrists within the Department of Psychiatry at the University of Florida.

Gary R Geffken, Ph.D. is an Associate Professor in Psychiatry and the Director of the UF OCD program. Dr. Geffken received his Ph.D. from the University of Florida in Clinical and Health Psychology. With over 20 years of experience in the treatment of OCD, Dr. Geffken has strived to maintain the clinic's active involvement in research. His most recent projects include predictors of treatment outcome in children with OCD.[8]

Joseph P.H. McNamara, Ph.D. serves as co-director of the UF OCD Program. Dr. McNamara received a in Ph.D. in Counseling Psychology from the University of Florida. During his time within the UF OCD Program, Dr. McNamara has extended the preexisting clinical research to directly examine the impact of sleep and executive functioning on children and adults with OCD. His research has also extended to include measure development.[9]

Cindi G. Flores, Ph.D. serves as assistant professor and co-director of the UF OCD Program. Dr. Flores received her Ph.D. in School Psychology from the University of Florida. Dr. Flores has a significant background in working with children with developmental delays, Autism Spectrum Disorders, and intellectual disabilities.[10] Dr. Flores' research interests include the intersection of Autism Spectrum Disorders and Anxiety Disorders.

Regina Bussing, M.D. is a board-certified child and adolescent psychiatrist who provides medical management for children and adolescents being treated within the UF OCD Program. Her primary clinical interests are combined pharmacological and behavioral treatment of patients with anxiety or disruptive disorders. Dr. Bussing's clinical research includes pharmacological treatment of OCD, and behavioral interventions for early childhood disruptive behavior disorders.

Mathew Nguyen, M.D., completed a psychiatric residency at Georgetown University and a child fellowship at the University of Florida. Currently, Dr. Nguyen serves the UF Department of Psychiatry as the Associate Chief and Medical Director of the-Division of Child and Adolescent Psychiatry. In this capacity he provides care and oversight to other medical providers in both inpatient and outpatient settings, including pharmacological treatment for OCD. In addition, Dr. Nguyen serves as Child Psychiatry’s Director of Medical Student Education.

Herb Ward, MD is currently working in the development of brain stimulation treatments for psychiatric diseases. His research in this area with Drs Foote, Okun, and Goodman have led to the University of Florida being one of the major sites in the evaluation of Deep Brain Stimulation [2] in OCD. He is also a key investigator in a RO-1 to evaluate Deep Brain Stimulation in major depression. [11]

References

  1. ^ Storch, E.A., Geffken, G.R., Merlo, L.J., Mann, G., Duke, D., Munson, M., Adkins, J., Grabill, K.M., Murphy, T.K. & Goodman, W.K. Family-Based Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder, T, Journal of the American Academy of Child & Adolescent Psychiatry, 46(4), 469-478.
  2. ^ Storch, E. A., Murphy, T. K., Lewin, A. B., Geffken, G. R., Johns, N., Jann, K. E., & Goodman, W. K. (2006). The Children’s Yale-Brown Obsessive Compulsive Scale: Psychometric Properties of Child- and Parent-Report Formats. Journal of Anxiety Disorders, 20, 1055-1070.
  3. ^ http://projectreporter.nih.gov/project_info_description.cfm?aid=7623839&icde=16978324&ddparam=&ddvalue=&ddsub=&cr=11&csb=default&cs=ASC
  4. ^ Meyer, J., McNamara, J. P. H., Reid, A. M., Storch, E. A., Geffken, G. R., Mason, D. M., Murphy, T. K., & Bussing, R. Prospective Relationship between Obsessive-Compulsive and Depressive Symptoms During Multimodal Treatment in Pediatric Obsessive-Compulsive Disorder. Child Psychiatry and Human Development
  5. ^ Storch, E. A., Murphy, T. K., Lewin, A. B., Geffken, G. R., Johns, N., Jann, K. E., & Goodman, W. K. (2006). The Children’s Yale-Brown Obsessive Compulsive Scale: Psychometric Properties of Child- and Parent-Report Formats. Journal of Anxiety Disorders, 20, 1055-1070.
  6. ^ Keeley, M.L., Geffken, G.R., Ricketts, E., McNamara, J.P.H., & Storch, E.A. The therapeutic alliance in the cognitive behavioral treatment of pediatric obsessive–compulsive disorder. Anxiety Disorders, 25(7), 855-863.
  7. ^ http://www.biologicalpsychiatryjournal.com/article/S0006-3223(10)00760-2/abstract
  8. ^ Mary L. Keeley, Gary R. Geffken, Emily Ricketts, Joseph P.H. McNamara, Eric A. Storch (2011). The therapeutic alliance in the cognitive behavioral treatment of pediatric obsessive–compulsive disorder. Anxiety Disorder, 25 (7), 855-863.
  9. ^ Regina Bussing, Tanya K. Murphy, Eric A. Storch, Joseph P.H. McNamara, Adam M. Reid, Cynthia W. Garvan, Wayne K. Goodman (2013). Psychometric properties of the Treatment-Emergent Activation and Suicidality Assessment Profile (TEASAP) in youth with OCD. Psychiatry Research, 205 (3), 253-261.
  10. ^ Soo-Jeong Kim, Raquel M Silva, Cindi G Flores, Suma Jacob, Stephen Guter, Gregory Valcante, Annette M Zaytoun, Edwin H Cook and Judith A Badner (2011). A quantitative association study of SLC25A12 and restricted repetitive behavior traits in autism spectrum disorders. Molecular Autism, 2 (8)
  11. ^ Right and left dorsolateral pre-frontal rTMS treatment of refractory depression: a randomized, sham-controlled trial. Triggs WJ, Ricciuti N, Ward HE, Cheng J, Bowers D, Goodman WK, Kluger BM, Nadeau SE. Psychiatry Res. 2010 Aug 15;178(3):467-74. Epub 2010 Jun 18.